Remove Biotech Remove Market Intelligence Remove Research
article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

And they used NetBase Quid to inform their research. We’ll provide a high-level summary here, and some practical applications of frameworks they’ve used that could apply to powering your own research on any number of topics. Investment intelligence to inform deep tech understanding. From here, the biotech world is your oyster.

Biotech 98
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96
article thumbnail

The Evolution of AI in Asset Management

Alpha Sense BI

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market. Artificial intelligence is the only way to do it.

article thumbnail

Slow Start to Venture Capital Funding in 2024

Alpha Sense BI

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?

Capital 69
article thumbnail

Global Precision Medicine Market is Expected to Reach $216.75 billion by 2028

BIS Research

This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.

article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

The Transformative Effect of Generative AI By 2025, it is estimated that more than 75% of venture capital (VC) and early-stage investor executive reviews will be informed using artificial intelligence (AI) and data analytics. There is no doubt that generative AI has emerged as a powerful tool in the investment space.

Capital 52